Gabor Egervari

Gabor Egervari

Auto-generated profile, based on publicly available information

Gabor Egervari

Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2018 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
XLXinjian Li
Xinjian Li
GEGabor Egervari
Gabor Egervari
YWYugang Wang
Yugang Wang
SBShelley L. Berger
Shelley L. Berger
ZLZhimin Lu
Zhimin Lu

23 October 2019 in Nature
Verified
Journal Article
Closed access
PDF file
PMP. Mews
P. Mews
GEG. Egervari
G. Egervari
RNR. Nativio
R. Nativio
Simone SidoliSimone Sidoli
Simone Sidoli
GDG. Donahue
G. Donahue
SBS. L. Berger
S. L. Berger

26 June 2018 in Genome Research
Verified
Journal Article
Open access
PDF file
JFJohn F. Fullard
John F. Fullard
MHMads E. Hauberg
Mads E. Hauberg
JBJaroslav Bendl
Jaroslav Bendl
GEGabor Egervari
Gabor Egervari
MCMaria-Daniela Cirnaru
Maria-Daniela Cirnaru
Panos RoussosPanos Roussos
Panos Roussos
Most common genetic risk variants associated with neuropsychiatric disease are noncoding and are thought to exert their effects by disrupting the function of cis regulatory elements (CREs), including promoters and enhancers. Within each cell, chromatin is arranged in specific patterns to expose the repertoire of CREs required for optimal spatiotemporal regulation of gene expression. To further understand the complex mechanisms that modulate transcription in the brain, we used frozen postmortem samples to generate the largest human brain and cell-type–specific open chromatin data set to date. Using the Assay for Transposase Accessible Chromatin followed by sequencing (ATAC-seq), we created maps of chromatin accessibility in two cell types (neurons and non-neurons) across 14 distinct brain regions of five individuals. Chromatin structure varies markedly by cell type, with neuronal chromatin displaying higher regional variability than that of non-neurons. Among our findings is an open chromatin region (OCR) specific to neurons of the striatum. When placed in the mouse, a human sequence derived from this OCR recapitulates the cell type and regional expression pattern predicted by our ATAC-seq experiments. Furthermore, differentially accessible chromatin overlaps with the genetic architecture of neuropsychiatric traits and identifies differences in molecular pathways and biological functions. By leveraging transcription factor binding analysis, we identify protein-coding and long noncoding RNAs (lncRNAs) with cell-type and brain region specificity. Our data provide a valuable resource to the research community and we provide this human brain chromatin accessibility atlas as an online database “Brain Open Chromatin Atlas (BOCA)” to facilitate interpretation.

2 January 2014 in Neuropsychopharmacology
Verified
Journal Article
Closed access
HSHenrietta Szutorisz
Henrietta Szutorisz
JDJennifer A DiNieri
Jennifer A DiNieri
ESEric Sweet
Eric Sweet
GEGabor Egervari
Gabor Egervari
MMMichael Michaelides
Michael Michaelides
YHYasmin L. Hurd
Yasmin L. Hurd

3 October 2018 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
MMMichael L Miller
Michael L Miller
BCBenjamin Chadwick
Benjamin Chadwick
DDDara L. Dickstein
Dara L. Dickstein
IPImmanuel Purushothaman
Immanuel Purushothaman
GEGabor Egervari
Gabor Egervari
YHYasmin L. Hurd
Yasmin L. Hurd
Neuronal circuits within the prefrontal cortex (PFC) mediate higher cognitive functions and emotional regulation that are disrupted in psychiatric disorders. The PFC undergoes significant maturation during adolescence, a period when cannabis use in humans has been linked to subsequent vulnerability to psychiatric disorders such as addiction and schizophrenia. Here, we investigated in a rat model the effects of adolescent exposure to Δ9-tetrahydrocannabinol (THC), a psychoactive component of cannabis, on the morphological architecture and transcriptional profile of layer III pyramidal neurons—using cell type- and layer-specific high-resolution microscopy, laser capture microdissection and next-generation RNA-sequencing. The results confirmed known normal expansions in basal dendritic arborization and dendritic spine pruning during the transition from late adolescence to early adulthood that were accompanied by differential expression of gene networks associated with neurodevelopment in control animals. In contrast, THC exposure disrupted the normal developmental process by inducing premature pruning of dendritic spines and allostatic atrophy of dendritic arborization in early adulthood. Surprisingly, there was minimal overlap of the developmental transcriptomes between THC- and vehicle-exposed rats. THC altered functional gene networks related to cell morphogenesis, dendritic development, and cytoskeleton organization. Marked developmental network disturbances were evident for epigenetic regulators with enhanced co-expression of chromatin- and dendrite-related genes in THC-treated animals. Dysregulated PFC co-expression networks common to both the THC-treated animals and patients with schizophrenia were enriched for cytoskeletal and neurite development. Overall, adolescent THC exposure altered the morphological and transcriptional trajectory of PFC pyramidal neurons, which could enhance vulnerability to psychiatric disorders.

23 October 2021 in Trends in Neurosciences
Verified
Journal Article
Closed access
GEGabor Egervari
Gabor Egervari
CSCody A. Siciliano
Cody A. Siciliano
EWEllanor L. Whiteley
Ellanor L. Whiteley
DRDorit Ron
Dorit Ron